[1]
G. Gritti, C. Pavoni, and A. Rambaldi, “IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?”, MJHID, vol. 9, no. 1, p. e2017010, Jan. 2017.